Matches 1 - 50 out of 174 1 2 3 4 >


Match Document Document Title
US20130005692 SYNERGISTIC COMPOSITION AND METHOD OF RETARDING AND AMELIORATING PHOTO INDUCED RETINAL DAMAGE AND CATARACTS WHILE AMELIORATING DRY EYE SYNDROME  
A composition and method of retarding and ameliorating eye diseases and injuries is disclosed. The method comprises administering a synergistic mixture of certain carotenoids, including the...
US20110021465 SYNERGISTIC COMPOSITION AND METHOD OF RETARDING AND AMELIORATING PHOTO INDUCED RETINAL DAMAGE AND CATARACTS WHILE AMELIORATING DRY EYE SYNDROME  
A composition and method of retarding and ameliorating eye diseases and injuries is disclosed. The method comprises administering a synergistic mixture of certain carotenoids, including the...
US20120225849 2-Methoxyestradiol (2-ME2) Prodrug with Enhanced Bioavailability for Prophylaxis or Treatment of Cancerous or Non-Cancerous Condition  
A prodrug of 2-methoxyestradiol (2-ME2) can be used for prophylaxis or treatment of cancer, such as esophageal cancer, prostate cancer, or breast cancer, and/or a non-cancerous condition, such as...
US20140274968 OMEGA-3 PHOSPHOLIPID SUPPLEMENTS FOR IMPROVED BRAIN MATURITY  
The invention relates to omega-3 phospholipid supplements for use in adolescents, and in particular to use omega-3 phospholipid supplements to improve or support brain maturity age. In preferred...
US20130338113 MATERIALS AND METHODS FOR TREATING VIRAL INFECTIONS  
The subject invention provides materials and methods for treating various health conditions, including the prevention and/or treatment of a viral infection. In a preferred embodiment, a cysteamine...
US20130281410 METHODS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS  
The invention provides methods for the treatment of major depressive disorder in male subjects and methods for the treatment of psychiatric disorders at high altitudes by administering one or more...
US20140080791 OMEGA-3 PHOSPHOLIPID SUPPLEMENTS FOR FEMALES  
The invention relates to omega-3 phospholipid supplements for females, and in particular to omega-3 phospholipid supplements with increased bioavailability as evidenced by increased EPA and DHA in...
US20110046083 ACTIVATORS OF PYRUVATE KINASE M2 AND METHODS OF TREATING DISEASE  
The invention described herein features methods, compositions, and kits for the use of activators of PKM2 for the treatment, prevention, or amelioration of diseases related to PKM2 function,...
US20150209374 Composition and Method for Curing Migraine Headaches  
The invention is directed to methods and compositions for curing migraine headaches. In particular, compositions are described involving the combination of dexamethasone, lidocaine, and thiamine....
US20150030541 NANOPARTICLE PEG MODIFICATION WITH H-PHOSPHONATES  
The present invention provides phosphonate conjugates and methods of preparing the phosphonate conjugates so as to allow, for example, improved methods and compounds for modifying the surface of a...
US20110177061 METHODS OF TREATING AND PREVENTING NEUROLOGICAL DISORDERS USING DOCOSAHEXAENOIC ACID  
The disclosure relates to methods of treating or preventing neurological disorders using docosahexaenoic acid.
US20120003158 Biomarkers for Inflammatory Bowel Disease and Methods Using the Same  
The present invention provides various biomarkers of inflammatory bowel disease, including biomarkers for Crohn's disease and biomarkers for Ulcerative colitis. The present invention also provides...
US20140371177 TREATMENT OF CANCER, INFLAMMATORY DISEASE, AND AUTOIMMUNE DISEASE  
A method of treating cancer, inflammatory disease, and autoimmune disease by administering to a subject in need thereof an effective amount of one or more 1,5-dipenylpenta-1,4-dien-3-one...
US20150231209 STIMULATION OF OVARIAN FOLLICLE DEVELOPMENT AND OOCYTE MATURATION  
Methods are provided for stimulating ovarian follicles in a mammal through disruption of the Hippo signaling pathway.
US20120148530 Method for the treatment or prevention of virus infection using polybiguanide-based compounds  
An inexpensive, easily available, and convenient method of treating or preventing a virus infection is provided. The present invention relates to a method for the treatment or prevention of virus...
US20120022024 ANTI-BACTERIAL COMPOSITIONS AND METHODS INCLUDING TARGETING VIRULENCE FACTORS OF STAPHYLOCOCCUS AUREUS  
This disclosure relates to compositions and methods including for the inhibition, prevention, and/or treatment of microbial infections, including infections from such pathogens as Staphylococcus...
US20110206743 NUTRITIONAL COMPOSITIONS WITH LIPID GLOBULES WITH A CORE COMPRISING VEGETABLE LIPIDS AND A COATING COMPRISING PHOSPHOLIPIDS OR POLAR LIPIDS  
The present invention relates to a nutritional composition for infants and/or toddlers comprising a lipid component which has a large lipid globule size. The composition can be used to prevent...
US20140044690 High-Energy Compounds for Use in Alzheimer's and Other Neurodegenerative Diseases  
A method of treating or preventing a neurodegenerative disease includes administering an effective amount of a compound to a subject in need thereof. The compound includes a high-energy compound,...
US20080292709 KITS FOR DHEA AND DHEA-SULFATE FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE  
Kits for treating or preventing chronic obstructive pulmonary disease (COPD) by using as active agent a non-glucorticoid steroid, analogue thereof, such as dehydroepiandrosterone (DHEA) and...
US20140088044 PRODUCT COMPRISING A NICOTINE-CONTAINING MATERIAL AND AN ANTI-CANCER AGENT  
The invention is directed to a product comprising a nicotine-containing material and an anti-cancer agent. The product is applicable in the treatment and/or prevention of cancer and precancerous...
US20110039700 Method for Improved Utilization of the Production Potential of Transgenic Plants Introduction  
The Invention discloses novel uses and methods for TSD directed to increasing the production potential of transgenic plants as well as methods for controlling unwanted animal pests on transgenic...
US20110275600 METHODS FOR INCREASING ENDOGENOUS PLASMALOGEN LEVELS  
The invention provides methods for increasing endogenous plasmalogen levels in an animal by administering to the animal an endogenous plasmalogen level increasing amount of one or more long chain...
US20110166106 ARTEMISININ AND DERIVATIVES THEREOF AS ANTIVIRALS  
Methods to treat various herpes viral infections using the natural product artemisinin and derivatives of that compound are described. The methods are especially applicable for treatment of...
US20120190620 METHODS TO IDENTIFY TARGETS AND MOLECULES REGULATING PURINOSOMES AND THEIR USES  
The present invention discloses methods to identify targets, pathways and molecules regulating purinosomes and their uses for treating pathophysiological disorders associated with purinosomes....
US20130225533 DOCOSAHEXAENOIC ACID BOUND IN PHOSPHOLIPIDS AND METHOD OF RECOVERING SAME FROM A NATURAL SOURCE  
Medicaments and therapeutic compositions contain (1) phospholipids having 4,7,10,13,16,19-docosahexaenoic acid covalently bound thereto and (2) at least one omega-3 polyunsaturated fatty acid, or...
US20100105635 COMPOSITION FOR PREVENTION OR TREATMENT OF DISEASE ASSOCIATED WITH AMYLOIDOSIS THROUGH INHIBITION OF AMYLOID PROTEIN AGGREGATION AND PROMOTION OF AMYLOID PROTEIN DEGRADATION  
It is an object of the present invention to provide a means for promoting amyloid protein degradation and a means for inhibiting amyloid protein aggregation. The present invention relates to a...
US20110098253 Nitrosated Nonsteroidal Antiinflammatory Compounds, Compositions and Methods of Use  
The invention also provides methods for treating inflammation, pain and fever; for treating gastrointestinal disorders; for facilitating wound healing; for treating and/or preventing...
US20110045102 Cancer chemotherapy compositions comprising PI3K pathway modulators and triptolide  
The present invention provides compositions and methods for inhibiting growth of and/or killing cancer cells. The compositions include: an inhibitor of the PI3K signal transduction pathway, and...
US20110124604 PHOSPHOLIPID RECEPTORS AS TARGETS FOR ENHANCING DRUG PERMEABILITY TO SELECTED TISSUES  
A method for enhancing drug delivery to the brain in neurological disorders using lysophosphatidic acid (LPA) and sphingosine I phosphate (S1P) is herein described. Specifically, the permeability...
US20050158355 Pesticide compositions and methods for their use  
Pesticide compositions and methods for their use are provided. Embodiments of the subject pesticide compositions include a pesticide and an assimilable carbon skeleton energy component....
US20110300225 NUTRITIONAL COMPOSITIONS WITH COATED LIPID GLOBULES  
The present invention relates to a nutritional composition for infants and/or toddlers comprising a lipid component which has a lipid globules coated with phospholipids. The composition is used...
US20140088045 PRODUCT COMPRISING A NICOTINE-CONTAINING MATERIAL AND AN ANTI-CANCER AGENT  
The present invention provides a composition comprising a nicotine-containing material and an anti-cancer agent usable in the treatment and/or prevention or reduction of the risk of cancer and...
US20050187195 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans  
The compounds of formula (I) are hydrophilic aryl phosphate, thiophosphate, and aminophosphate intestinal apical membrane Na-mediated phosphate co-transportation inhibitors. The compounds can be...
US20130137571 Crystalline Modification of Fipronil  
The present invention relates to a novel crystalline modification of fipronil, to a process for the preparation of the same, to pesticidal and parasiticidal mixtures and compositions comprising...
US20150224075 OMEGA 3 FORMULATIONS FOR TREATMENT OF RISK FACTORS FOR CARDIOVASCULAR DISEASE AND PROTECTION AGAINST SUDDEN DEATH  
A formulation for treating omega-3 fatty acid deficiency is disclosed containing about 90% or more omega 3 fatty acids by weight comprised of a combination of Eicosapentaenoic acid (EPA),...
US20080242640 Surfactant Lipids, Compositions Thereof and Uses Thereof  
The invention generally relates to methods to inhibit inflammation or pathogen infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an...
US20120316108 PHOSPHOLIPID DEPOT  
The present invention is directed to compositions and methods of preparation of phospholipid depots that are injectable through a fine needle.
US20110207703 OXIDIZED LIPID COMPOUNDS AND USES THEREOF  
Novel oxidized lipids are provided herein, as well as methods for producing same, and uses thereof in treating or preventing an inflammation associated with endogenous oxidized lipids and related...
US20060286039 Novel treatment for pathological aggression  
The use of compounds belonging to the class of substituted pentanedioic acids to control aggressive behavior provides new means of treatment for this syndrome.
US20080318908 USE OF GABA AND GABAB AGONISTS  
The present invention provides methods of stimulating tissue growth, including islet cell growth, by administering GABA or a GABA agonist to act on GABAB receptors and GABAB-like receptors to...
US20120077780 Fat Accumulation Inhibitor and Method of Use Thereof  
The present disclosure relates to a method of inhibiting a fat accumulation for a fat cell in a subject, which includes administering a fat accumulation inhibitor for a fat cell which includes a...
US20140141972 ANTHRANILAMIDE ARTHROPODICIDE TREATMENT  
This invention pertains to methods for protecting a propagule or a plant grown therefrom from invertebrate pests comprising contacting the propagule or the locus of the propagule with a...
US20110165264 USE OF CILASTATIN TO REDUCE NEPHROTATOXICITY OF VARIOUS COMPOUNDS  
Use of cilastatin to reduce the nephrotoxicity of different compounds. The invention refers to use of cilastatin to prepare a medicinal product to reduce the nephrotoxicity of a nephrotoxic...
US20090291908 Use of thiophoshonoformic acid and nrtis to treat viral infections  
This invention provides for a method of synergistically reducing viral load in a patient infected with a virus. The method comprises the oral co-administering an amount of thiophosphonoformic acid...
US20120009150 DIARYL UREAS FOR TREATING VIRUS INFECTIONS  
The present invention relates to pharmaceutical compositions for treating virus infections and/or diseases caused by virus infections comprising at least a diaryl urea compound optionally combined...
US20100298274 FAT CONTAINING COMPOSITION  
A composition comprises a fat phase wherein the fat phase comprises: more than 10 wt. % DHA and/or EPA or derivatives thereof; or more than 5 wt. % GLA or a derivative thereof; or more than 10 wt....
US20120122679 MESOIONIC PESTICIDES  
Disclosed are compounds of Formula 1, N-oxides and salts thereof, wherein X is O or S;Y is O or S;Z is a direct bond, O, S(O)n, NR6, C(R7)2O, OC(R7)2, EC(═X1);a is 1, 2 or 3;and R1, R2, R3, R4,...
US20050065121 Methods to increase plasma HDL cholesterol levels and improve HDL functionality with probucol monoesters  
It has been discovered that certain selected probucol monoesters, and their pharmaceutically acceptable salts or prodrugs, are useful for increasing circulating HDL cholesterol. These compounds...
US20120035135 Treatment of Transgenic Crops with Mixtures of Fiproles and Chloronicotinyls  
The Invention relates to methods for increasing the production potential of plants and/or controlling pests in plants with at least one transgenic modification related to yield increase as...
US20140170112 COMPOSITIONS FOR AMELIORATING SYSTEMIC INFLAMMATION AND METHODS FOR MAKING AND USING THEM  
In alternative embodiments the invention provides compositions, e.g., pharmaceutical compositions and preparations, formulations, kits and other products of manufacture, e.g., exemplary drug...

Matches 1 - 50 out of 174 1 2 3 4 >